Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

Cambridge University Hospitals NHS Foundation Trust, an NHS healthcare organisation, is procuring a digital PCR or digital droplet PCR system for high-sensitivity quantitative molecular testing in haematological oncology. The contract covers supply, delivery, installation, commissioning and post-warranty maintenance of the equipment, which will complement existing next-generation sequencing, quantitative PCR and fragment-analysis capabilities and support diagnosis, disease monitoring and assessment of therapeutic response. The system is also intended to enable consolidation of multiple existing assays and methodologies onto one technology platform. The estimated contract value is £270,000, although the available details do not specify the contract duration or delivery timeframe. Delivery is required in the UKH12 region of the United Kingdom, with the equipment expected to serve the Cambridge Genomics Lab. The critical qualification requirement is the ability to provide and commission a dPCR or ddPCR system capable of supporting clinically relevant haemato-oncology assays and associated post-warranty maintenance.

Buyer: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST. Source: Find a Tender. Updated 16 Nov 2026.

Key facts

  • Estimated value: £270k
  • Bids close: 16 Dec 2026
  • Location: Cambridgeshire CC
  • Procedure: Open procedure
  • Contract period: 1 Mar 2027 to 28 Feb 2034
  • Category: Polymerase Chain Reaction (PCR) equipment (38950000)

From the official notice

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

View the official notice

Questions about this tender

When is the deadline?

Bids close on 16 Dec 2026.

What is it worth?

The estimated value is £270k.

Who can apply?

Any supplier that meets the buyer's requirements can apply. Check the official notice for conditions.

How do I bid?

Open the official notice, register on the buyer's portal and submit your bid before the deadline.

Similar tenders

Contains public sector information licensed under the Open Government Licence v3.0.

See all live tenders